Palbociclib showed antiproliferative activity in early-stage breast cancer
The molecularly targeted therapeutic palbociclib (Ibrance), which is used to treat advanced breast cancer, was effective in slowing the multiplication of cancer cells in patients diagnosed with early-stage breast cancer who ...
Apr 19, 2016
0
3